Sigmund Named Head of Pharmacology
Curt D. Sigmund, PhD, has been named professor and head of the Department of Pharmacology in the UI Carver College of Medicine. Sigmund is a faculty member in the departments of internal medicine and molecular physiology and biophysics. He will retain joint appointments with both departments.
Sigmund joined the UI Carver College of Medicine faculty in 1991 as an assistant professor in the Cardiovascular Division of Internal Medicine and in Molecular Physiology and Biophysics. In 1997 he was appointed associate professor, and in 2001 as professor. He is also the director of the Center on Functional Genomics of Hypertension and director of the Roy J. Carver Program of Research Excellence in the Functional Genomics of Cardiovascular Disease. In 2008 he was named the Roy J. Carver Chair in Hypertension Research. In addition to his research and teaching responsibilities, he has also served on many departmental, collegiate, UI, and national committees, including chair of the National Heart, Lung and Blood Institute Program Project Review Committee.
Perlman Elected to Academy
Stanley Perlman, MD, PhD, professor of microbiology and pediatrics, has been elected a fellow of the American Academy of Microbiology. The honor recognizes scientific achievement and original contributions that have advanced microbiology. He was one of 78 scientists elected to the academy this year.
Fuentes Receives CAREER Award
Ernesto Fuentes, PhD, assistant professor of biochemistry, has received a five-year $1 million CAREER award from the National Science Foundation (NSF). The grant is NSF’s most prestigious award for junior faculty who exemplify the role of scholar-teacher by integrating outstanding research with excellent teaching.
NIH Grant to Help UI Team Counter Antibiotic Resistance
Research in the UI College of Pharmacy aims to disrupt the ability of tuberculosis-causing bacteria to mutate and become ever more resistant to antibiotics. The project has been funded by a five-year, nearly $1.9 million grant from the National Institutes of Health.
The study's principal investigator Robert Kerns, PhD, UI associate professor of medicinal and natural products chemistry hopes to develop novel inhibitors of certain to restrict the ability of the bacteria to mutate and become resistant. While the UI effort is focused on tuberculosis, the findings might eventually help with efforts to develop improved antibiotics for other diseases.
|
